Search

Your search keyword '"Tybjærg-Hansen, A"' showing total 3,380 results

Search Constraints

Start Over You searched for: Author "Tybjærg-Hansen, A" Remove constraint Author: "Tybjærg-Hansen, A"
3,380 results on '"Tybjærg-Hansen, A"'

Search Results

1. Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis.

4. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

6. Contributors

9. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer’s Disease in Nordic Populations

10. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

11. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

15. Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis

17. Stroke genetics informs drug discovery and risk prediction across ancestries

18. ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma

19. Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis

23. New insights into the genetic etiology of Alzheimer’s disease and related dementias

24. Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride

25. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.

27. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

28. Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile

29. Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes

31. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease

32. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

33. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms

34. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

35. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

44. Epigenetic Regulation of F2RL3 Associates with Myocardial Infarction and Platelet Function

46. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries

47. Polygenic risk scores for cardiovascular risk prediction:moving towards implementation into clinical practice?

49. Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome

50. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?

Catalog

Books, media, physical & digital resources